Tas13D Inhibits Growth of SMMC-7721 Cell via Suppression VEGF and EGF Expression |
He, Huai-Zhen
(School of Medicine, Xi'an Jiaotong University)
Wang, Nan (School of Medicine, Xi'an Jiaotong University) Zhang, Jie (School of Medicine, Xi'an Jiaotong University) Zheng, Lei (School of Medicine, Xi'an Jiaotong University) Zhang, Yan-Min (School of Medicine, Xi'an Jiaotong University) |
1 | Carmeliet P (2005). Angiogenesis in life, disease and medicine. Nature, 438, 932-6. DOI ScienceOn |
2 | Desbois-Mouthon C, Cacheux W, Blivet-Van Eggelpoel MJ, et al (2006). Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib. Int J Cancer, 119, 2557-66. DOI |
3 | Fayad W, Fryknas M, Brnjic S, et al (2009). Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters. Plos One, 4, e7238. DOI |
4 | Folkman J (1992). Introduction angiogenesis and cancer, Semin. Cancer Biol, 3, 47-8. |
5 | Han SW, Hwang PG, Chung DH, et al (2005). Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer. Int J Cancer, 113, 109-15. DOI |
6 | Harichand-Herdt S, Ramalingam SS (2008). Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor. Semin Thorac Cardiovasc Surg, 20, 217-23. DOI |
7 | Hirsch FR, Varella-Garcia M, Bunn PA, et al (2006). Molecular predictors of outcome with gefitinib in a phase III placebocontrolled study in advanced nonsmall-cell lung cancer. J Clin Oncol, 24, 5034-42. DOI ScienceOn |
8 | Ishiwata I, Sudo T, Kiguchi K, et al (1999). Tumor angiogenesis factors produced by cancer cells. Hum Cell, 12, 37-46. |
9 | Kelly TR, Xie RL (1998). Total synthesis of taspine. J Org Chem, 63, 8045-8. DOI |
10 | Kerbel RS (2000). Tumour angiogenesis: past, present and the near future. Carcinogenesis, 21, 505-15. DOI ScienceOn |
11 | Kim ES, Khuri FR, Herbst RS (2001). Epidermal growth factor receptor biology (IMC-C225). Curr Opin Oncol, 13, 506-13. DOI ScienceOn |
12 | Klein S, Levitzki A (2009). Targeting the EGFR and the PKB pathway in cancer. Curr Opin Cell Biol, 21, 185-93. DOI |
13 | Li ZH, Zhao RJ, Wu XH, et al (2005). Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J, 19, 1979-85. |
14 | Liang GB, Zhang GP, Jin HM (2005). Influence of basic fibroblast growth factor on ECV304 cell migration. Chin J Pathophysiol, 21, 16-20. |
15 | Lin CM, Chang H, Chen YH, et al (2006). Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int Immunopharmacol, 6, 1690-8. DOI ScienceOn |
16 | Martinez A (2006). A new family of angiogenic factors. Cancer Lett, 36, 157-63 |
17 | Mou J, Fang H, Jing F, et al (2009). Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors. Bioorg Med Chem, 17, 4666-73. DOI |
18 | Mu H, Ohashi R, Yan S, et al (2006). Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res, 70, 146-57. DOI ScienceOn |
19 | Myoung H, Hong SP, Yun PY, et al (2003). Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Cancer Sci, 94, 215-20. DOI ScienceOn |
20 | Naruse I, Ohmori T, Ao Y, et al (2002). Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFRexpressing multidrug-resistant cell line in vitro and in vivo. Int J Cancer, 98, 310-5. DOI ScienceOn |
21 | Perdue GP, Blomster RN, Blake DA, et al (1979). South American plants II: taspine isolation and anti-inflammatory activity. J Pharm Sci, 68, 124-6. DOI |
22 | Shimamura M, Hazato T, Ashino H, et al (2001).Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Biochem Biophys Res Commun, 289, 220-4. DOI |
23 | Shyu KG, Tsai SC, Wang BW, et al (2004). Saikosaponin C induces endothelial cells growth, migration and capillary tube formation. Life Sci, 76, 813-26. DOI |
24 | Sikander M, Malik S, Yadav D, et al (2011). Cytoprotective activity of a trans-chalcone against hydrogen peroxide induced toxicity in hepatocellular carcinoma (HepG2) cells. Asian Pac J Cancer P, 12, 2513-6. |
25 | Yu T, Hou FG, Liu MM, et al (2012). Norcantharidin antiangiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer. Asian Pac J Cancer P, 13, 499-503. DOI |
26 | Uchida C, Haas TL (2009). Evolving strategies in manipulating VEGF/VEGFR signaling for the promotion of angiogenesis in ischemic muscle. Curr Pharm Des, 15, 411-21. DOI |
27 | Yancopoulos GD, Davls S, Gale NW, et al (2000). Vascularspecific growth factors and blood vessel formation. Nature, 407, 242-8. DOI ScienceOn |